Article Information
History
- March 17, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Leticia Monin-Aldama1,*,
- Adam G. Laing2,*,
- Miguel Muñoz-Ruiz1,*,
- Duncan R McKenzie1,*,
- Irene del Molino del Barrio2,3,*,
- Thanussuyah Alaguthurai4,5,*,
- Clara Domingo-Vila2,
- Thomas S. Hayday2,
- Carl Graham6,
- Jeffrey Seow6,
- Sultan Abdul-Jawad4,
- Shraddha Kamdar2,
- Elizabeth Harvey-Jones5,
- Rosalind Graham4,
- Jack Cooper7,
- Muhammad Khan7,
- Jennifer Vidler8,
- Helen Kakkassery4,
- Sinha Shubhankar4,
- Richard Davis2,
- Liane Dupont5,
- Isaac Francos Quijorna9,
- Puay Lee1,
- Josephine Eum2,
- Maria Conde Poole2,
- Magdalene Joseph2,
- Daniel Davies2,
- Yin Wu2,4,
- Ana Montes7,
- Mark Harries7,
- Anne Rigg7,
- James Spicer4,7,
- Michael H Malim6,
- Paul Fields4,8,
- Piers Patten1,8,
- Francesca Di Rosa10,
- Sophie Papa4,7,
- Tim Tree2,
- Katie Doores6,
- Adrian C. Hayday1,2,*,^ and
- Sheeba Irshad4,5,7,11,*,^
- 1The Francis Crick Institute, London, UK
- 2Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King’s College London, London, UK
- 3UCL Cancer Institute, University College London, London, UK
- 4Comprehensive Cancer Centre, School of Cancer & Pharmaceutical Sciences, King’s College London, London, UK
- 5Breast Cancer Now Research Unit, King’s College London, London, UK
- 6Department of Infectious Diseases, School of Immunology & Microbial Sciences, King’s College London, London, UK
- 7Guy’s and St Thomas’ NHS Foundation Trust, London, UK
- 8Department of Haematological Medicine, King’s College Hospital, London, UK
- 9Regeneration Group, Wolfson Centre for Age-Related Diseases, IoPPN, King’s College London, London, UK
- 10Institute of Molecular Biology and Pathology, National Research Council of Italy (CNR), Rome, Italy
- 11Cancer Research UK (CRUK) Clinician Scientist, London, UK
- ↵^co-corresponding authors: adrian.hayday{at}kcl.ac.uk and sheeba.irshad{at}kcl.ac.uk
↵* equal contributions
Posted March 17, 2021.
Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority guidelines
